LOSS OF AMPLIFIED EGFR GENE WITH MUTATION AS A NOVEL MECHANISM OF ACQUIRED RESISTANCE TO EGFR-TKIS IN EGFR MUTATED NSCLC CELLS

被引：0
|
作者：
Furugaki, K. [1 ]
Iwai, T. [1 ]
Moriya, Y. [1 ]
Fujimoto-Ouchi, K. [2 ]
机构：
[1] Chugai Pharmaceut Co Ltd, Prod Res Dept, Kamakura, Kanagawa, Japan
[2] Chugai Pharmaceut Co Ltd, Discovery Pharmacol Dept, Kamakura, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：390 / 391
页数：2
相关论文
共 50 条
  • [1] Loss of an EGFR-amplified chromosome 7 as a novel mechanism of acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC cells
    Furugaki, Koh
    Iwai, Toshiki
    Moriya, Yoichiro
    Harada, Naoki
    Fujimoto-Ouchi, Kaori
    LUNG CANCER, 2014, 83 (01) : 44 - 50
  • [2] Effect of loss of a chromosome 7 containing multiple copies of EGFR gene on acquired resistance to EGFR-TKIs in EGFR mutated NSCLC.
    Furugaki, Koh
    Iwai, Toshiki
    Moriya, Yoichiro
    Fujimoto-Ouchi, Kaori
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs
    Oya, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S622 - S622
  • [4] Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
    Wen, Miaomiao
    Xia, Jinghua
    Sun, Ying
    Wang, Xuejiao
    Fu, Xianghui
    Zhang, Yanning
    Zhang, Zhipei
    Zhou, Yongan
    Li, Xiaofei
    BIOLOGICS-TARGETS & THERAPY, 2018, 12 : 183 - 190
  • [5] EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis
    Ao Liu
    Xiaoming Wang
    Lian Wang
    Han Zhuang
    Liubo Xiong
    Xiao Gan
    Qian Wang
    Guanyu Tao
    BMC Cancer, 24 (1)
  • [6] Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs.
    Oya, Yuko
    Yoshida, Tatsuya
    Tanaka, Kosuke
    Shimizu, Junichi
    Horio, Yoshitsugu
    Sakao, Yukinori
    Hida, Toyoaki
    Yatabe, Yasushi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Correction: EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis
    Ao Liu
    Xiaoming Wang
    Lian Wang
    Han Zhuang
    Liubo Xiong
    Xiao Gan
    Qian Wang
    Guanyu Tao
    BMC Cancer, 25 (1)
  • [8] Continued EGFR-TKIs treatment promotes the survival of elderly patients with acquired resistance to EGFR-TKIs therapy
    Wang, P.
    Zhang, D.
    Li, X. -M.
    Guo, X. -G.
    Sun, B. -J.
    Fang, X. -Q.
    Qu, G. -P.
    An, L.
    Liu, C. -T.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (11) : 2450 - 2459
  • [9] Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation
    Daoan Cheng
    Banglu Wang
    Lige Wu
    Rui Chen
    Weiqing Zhao
    Cheng Fang
    Mei Ji
    Medical Oncology, 40
  • [10] Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation
    Cheng, Daoan
    Wang, Banglu
    Wu, Lige
    Chen, Rui
    Zhao, Weiqing
    Fang, Cheng
    Ji, Mei
    MEDICAL ONCOLOGY, 2023, 40 (09)
12345